Literature DB >> 15791705

Cancer of the ovary.

Ching-Ming Liu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15791705

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

Review 1.  A brief review of the management of platinum-resistant-platinum-refractory ovarian cancer.

Authors:  Bryan Oronsky; Carolyn M Ray; Alexander I Spira; Jane B Trepel; Corey A Carter; Hope M Cottrill
Journal:  Med Oncol       Date:  2017-04-25       Impact factor: 3.064

2.  Genomic and Epigenomic Signatures in Ovarian Cancer Associated with Resensitization to Platinum Drugs.

Authors:  Fang Fang; Horacio Cardenas; Hao Huang; Guanglong Jiang; Susan M Perkins; Chi Zhang; Harold N Keer; Yunlong Liu; Kenneth P Nephew; Daniela Matei
Journal:  Cancer Res       Date:  2017-12-11       Impact factor: 12.701

3.  A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer.

Authors:  Fang Fang; Curt Balch; Jeanne Schilder; Timothy Breen; Shu Zhang; Changyu Shen; Lang Li; Carol Kulesavage; Anthony J Snyder; Kenneth P Nephew; Daniela E Matei
Journal:  Cancer       Date:  2010-09-01       Impact factor: 6.860

4.  DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma.

Authors:  Noriko Yamaguchi; Rei Mimoto; Nozomu Yanaihara; Yoshimi Imawari; Shinichi Hirooka; Aikou Okamoto; Kiyotsugu Yoshida
Journal:  Tumour Biol       Date:  2015-02-25

Review 5.  Minireview: epigenetic changes in ovarian cancer.

Authors:  Curt Balch; Fang Fang; Daniela E Matei; Tim H-M Huang; Kenneth P Nephew
Journal:  Endocrinology       Date:  2009-07-02       Impact factor: 4.736

6.  Comprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkers.

Authors:  Rui-Lan Huang; Fei Gu; Nameer B Kirma; Jianhua Ruan; Chun-Liang Chen; Hui-Chen Wang; Yu-Ping Liao; Cheng-Chang Chang; Mu-Hsien Yu; Jay M Pilrose; Ian M Thompson; Hsuan-Cheng Huang; Tim Hui-Ming Huang; Hung-Cheng Lai; Kenneth P Nephew
Journal:  Epigenetics       Date:  2013-05-10       Impact factor: 4.528

7.  Epigenetic targeting of ovarian cancer stem cells.

Authors:  Yinu Wang; Horacio Cardenas; Fang Fang; Salvatore Condello; Pietro Taverna; Matthew Segar; Yunlong Liu; Kenneth P Nephew; Daniela Matei
Journal:  Cancer Res       Date:  2014-07-17       Impact factor: 12.701

Review 8.  Epigenetic therapies for chemoresensitization of epithelial ovarian cancer.

Authors:  Daniela E Matei; Kenneth P Nephew
Journal:  Gynecol Oncol       Date:  2009-10-24       Impact factor: 5.482

9.  A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer.

Authors:  Amit M Oza; Ursula A Matulonis; Angeles Alvarez Secord; John Nemunaitis; Lynda D Roman; Sarah P Blagden; Susana Banerjee; William P McGuire; Sharad Ghamande; Michael J Birrer; Gini F Fleming; Merry Jennifer Markham; Hal W Hirte; Diane M Provencher; Bristi Basu; Rebecca Kristeleit; Deborah K Armstrong; Benjamin Schwartz; Patricia Braly; Geoff D Hall; Kenneth P Nephew; Simone Jueliger; Aram Oganesian; Sue Naim; Yong Hao; Harold Keer; Mohammad Azab; Daniela Matei
Journal:  Clin Cancer Res       Date:  2019-12-12       Impact factor: 12.531

10.  Investigation of the expression patterns and correlation of DNA methyltransferases and class I histone deacetylases in ovarian cancer tissues.

Authors:  Yifeng Gu; Peifang Yang; Qing Shao; Xia Liu; Sheng Xia; Miaomiao Zhang; Huaxi Xu; Qixiang Shao
Journal:  Oncol Lett       Date:  2012-12-03       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.